TP53 and lung carcinoma: Some reports indicate that EP300 acetylates, stabilizes, and activates p53 overexpression of which inhibits caspase 9 in the human lung cancer cell line H1299, thereby allowing these cells to avoid cisplatin-induced apoptosis [23,24].